New vaccine introduced for highly infectious respiratory illness

The AREXVY vaccine will be available for those aged 60 and over privately to prevent the respiratory syncytial virus.

Related Keywords

Sydney ,New South Wales ,Australia ,United States ,Bowral ,Australian ,Australians ,Alan Paul ,Catherine Hughes ,Immunisation Foundation Of Australia ,Therapeutic Goods Administration ,National Notifiable Disease Surveillance System ,Country Medical Director ,G Sk Australia ,Immunisation Foundation ,